| Mr Ian John Mahase, PT | |
|
10303 Rockaway Blvd, Ozone Park, NY 11417-2232 | |
| (646) 641-0729 | |
| Not Available |
| Full Name | Mr Ian John Mahase |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 23 Years |
| Location | 10303 Rockaway Blvd, Ozone Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922313873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 020924 (New York) | Primary |
| Provider Name | Ahava Medical And Rehabilitation Center, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184878274 PECOS PAC ID: 1557416997 Enrollment ID: O20090908000443 |
News Archive
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
Although we spend a lot of our time online nowadays-streaming music and video, checking email and social media, or obsessively reading the news-few of us know about the mathematical algorithms that manage how our content is delivered.
Global nanotechnology company pSivida Limited has announced that its evaluation of selected compounds from an undisclosed top five global pharmaceutical company has progressed successfully.
Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.
› Verified 9 days ago
| Provider Name | Professional Pt Ot Services Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1356981039 PECOS PAC ID: 2264868637 Enrollment ID: O20200203000995 |
News Archive
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
Although we spend a lot of our time online nowadays-streaming music and video, checking email and social media, or obsessively reading the news-few of us know about the mathematical algorithms that manage how our content is delivered.
Global nanotechnology company pSivida Limited has announced that its evaluation of selected compounds from an undisclosed top five global pharmaceutical company has progressed successfully.
Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.
› Verified 9 days ago
| Provider Name | Anchor Health Homecare Services Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1356071237 PECOS PAC ID: 2163802570 Enrollment ID: O20220701001011 |
News Archive
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
Although we spend a lot of our time online nowadays-streaming music and video, checking email and social media, or obsessively reading the news-few of us know about the mathematical algorithms that manage how our content is delivered.
Global nanotechnology company pSivida Limited has announced that its evaluation of selected compounds from an undisclosed top five global pharmaceutical company has progressed successfully.
Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Ian John Mahase, PT 10303 Rockaway Blvd, Ozone Park, NY 11417-2232 Ph: (646) 641-0729 | Mr Ian John Mahase, PT 10303 Rockaway Blvd, Ozone Park, NY 11417-2232 Ph: (646) 641-0729 |
News Archive
Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or slowed down.
Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.
Although we spend a lot of our time online nowadays-streaming music and video, checking email and social media, or obsessively reading the news-few of us know about the mathematical algorithms that manage how our content is delivered.
Global nanotechnology company pSivida Limited has announced that its evaluation of selected compounds from an undisclosed top five global pharmaceutical company has progressed successfully.
Results of two studies funded by Project A.L.S. and appearing in the advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.
› Verified 9 days ago
Amanda Joy Volpe, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10315 101st St, Ozone Park, NY 11417 Phone: 718-843-1333 | |
Ms. Helen L. Aguilar, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9747 85th St, Ozone Park, NY 11416 Phone: 718-843-0419 | |
Mr. Armin Nunez Tinio, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8815 133rd Ave, # 2b, Ozone Park, NY 11417 Phone: 917-698-6892 | |
Mrs. Omayra Carrasquillo, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10606 76th St, Ozone Park, NY 11417 Phone: 347-203-9780 | |
Dr. Ai Mei Yu, P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10718 105th St, Ozone Park, NY 11417 Phone: 646-280-5688 | |
Geetika Motwani, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10352 97th St Apt 2, Ozone Park, NY 11417 Phone: 646-717-2830 | |
Michelle Argana Reyes, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9049 Silver Rd, Ozone Park, NY 11417 Phone: 718-805-6537 |